Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

This study has been terminated.

(Sponsor has designed another study to replace the current study)

Sponsor:

Information provided by (Responsible Party):

Zensun Sci. & Tech. Co., Ltd.

ClinicalTrials.gov Identifier:

NCT01131637

First received: May 25, 2010

Last updated: August 1, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	December 2012
Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)